Beta Bionics, Inc.
BBNX
$28.31
-$1.07-3.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.27% | -60.33% | -- | -- | -- |
| Total Depreciation and Amortization | 7.44% | 42.66% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.83% | 23.01% | -- | -- | -- |
| Change in Net Operating Assets | -10.76% | -58.85% | -- | -- | -- |
| Cash from Operations | -40.25% | -87.00% | -- | -- | -- |
| Capital Expenditure | -25.68% | -274.71% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -369.11% | -217.94% | -- | -- | -- |
| Cash from Investing | -344.76% | -219.39% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 292,847.95% | 782,288.89% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -109.25% | -3,284.87% | -- | -- | -- |
| Cash from Financing | 21,449.05% | 290,183.70% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.70% | 124.64% | -- | -- | -- |